Stay updated on Prevnar 13/Pneumovax 23 Safety/Immunogenicity in Adults 50+ Clinical Trial
Sign up to get notified when there's something new on the Prevnar 13/Pneumovax 23 Safety/Immunogenicity in Adults 50+ Clinical Trial page.

Latest updates to the Prevnar 13/Pneumovax 23 Safety/Immunogenicity in Adults 50+ Clinical Trial page
- ChecktodayChange DetectedFooter Revision updated from v3.6.5 to v3.6.6, indicating a new page build; this is an administrative update applied to the page.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5. This indicates a minor site maintenance update rather than a change to study content or data.SummaryDifference0.1%

- Check35 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing the previous Revision: v3.6.3. This indicates an update to the page version in the site's revision history.SummaryDifference0.1%

- Check57 days agoChange DetectedThe page now displays Revision: v3.6.3, replacing the previous revision label. This indicates an update to the page or platform version, removing the older v3.6.2 label.SummaryDifference0.1%

- Check64 days agoChange DetectedRevision label updated from v3.6.0 to v3.6.2 to reflect a new software build. No study content or data on the page is affected by this change.SummaryDifference0.1%

- Check78 days agoChange DetectedAdded the exact recruitment status phrase 'No longer looking for participants' and introduced new help/navigation sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study'). Also, the 'Intervention/Treatment' label formatting was updated and the site revision moved to v3.6.0.SummaryDifference0.5%

Stay in the know with updates to Prevnar 13/Pneumovax 23 Safety/Immunogenicity in Adults 50+ Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Prevnar 13/Pneumovax 23 Safety/Immunogenicity in Adults 50+ Clinical Trial page.